Depletion of intracellular magnesium inducing an altered activity of the tyrosine kinase insulin receptor, as well as all other magnesium-dependent kinases of the insulin signaling, impairs insulin sensitivity and may contribute to the development of clinical conditions associated with a reduced insulin sensitivity, such as glucose intolerance, type 2 diabetes and hypertension. This evidence concerns the gene INS and type 2 diabetes mellitus.